2617 Parkinson
Oryginalny tytuł ogłoszenia
Norway – Medical equipments, pharmaceuticals and personal care products – 2617 Parkinson
Ocena szansy
Skąd ta ocena?
Szansa
45 / 100
Złożoność
40 / 100
Czynniki ryzyka
The absence of estimated contract value prevents bidders from assessing potential revenue and deciding whether to bid.
Award criteria are not specified, making it impossible to know how tenders will be evaluated.
Submission deadline in 3 days
Głęboka analiza portfolio
Wykorzystuje:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Przegląd
Moderate opportunityKluczowe fakty
- Framework procurement
- Supplies contract
- 1 lot
- Duration until Oct 2028
- Procurement of a new medicine for treatment of Parkinson's disease.
- Supply to four regional health authorities in Norway.
Pokaż pełne podsumowanie
This tender, issued by Sykehusinnkjøp HF on behalf of the four regional health authorities in Norway, seeks to procure a new medicine for the treatment of Parkinson's disease. It is an open procedure for a supply framework agreement. The deadline for submission is 28 August 2026. The estimated contract value is not provided. Analysis is based solely on the structured notice and XML notice; procurement documents were not analyzed.
Ryzyka
The absence of estimated contract value prevents bidders from assessing potential revenue and deciding whether to bid.
Award criteria are not specified, making it impossible to know how tenders will be evaluated.
Submission deadline in 3 days
Analiza może być niepełna
Przeanalizowano tylko część dokumentacji. Pozostałe dokumenty mogą zawierać dodatkowe wymagania, certyfikaty lub dokumenty do złożenia.
Kluczowe wymagania
Administrative
- Tenderers must submit an ESPD (European Single Procurement Document).
- Electronic submission is required via the provided portal.
- Tenders must be submitted in Norwegian (as per language setting).
Wymagania mogą być niepełne.
Zamawiający
Nazwa
Lokalizacja
VADSØ, NOR
Profil zamawiającego
Identyfikator
916879067
Działalność
Health
Części (1)
LOT-0001
2617 Parkinson
Procurement of a new medicine for the treatment of Parkinson's disease, to be supplied to the four regional health authorities in Norway. The framework agreement is expected to run from 1 November 2026 to 31 October 2028.
Lokalizacja
Czas trwania
Kategoria
Termin
Szczegóły kryteriów
Sykehusinnkjøp HF, division Legemidler shall, on behalf of the four regional health authorities, procure medicines for the treatment of Parkinson disease. The contracting authority for this competition is Sykehusinnkjøp HF, on behalf of the four regional health authorities in Norway: Helse Sør-Øst RHF, Helse Vest RHF, Helse Midt-Norway RHF and Helse Nord RHF.
Uwaga do wartości
Pokaż oryginalne dane TED
Oryginalny opis TED
Sykehusinnkjøp HF, division Legemidler shall, on behalf of the four regional health authorities, procure medicines for the treatment of Parkinson disease. The contracting authority for this competition is Sykehusinnkjøp HF, on behalf of the four regional health authorities in Norway: Helse Sør-Øst RHF, Helse Vest RHF, Helse Midt-Norway RHF and Helse Nord RHF.
Szczegóły zamówienia
- Data publikacji
- 27 May 2026
- Języki
- English, Norwegian
Metadane referencyjne
- Podstawa prawna
- 32014L0024
Identyfikatory referencyjne
- ID przetargu
- 364142-2026
Dokumenty (1)
Podobne przetargi
Belgium – Bedroom, dining room and living-room furniture – Fourniture de mobilier de chambre
Denmark – Medical equipments, pharmaceuticals and personal care products – Fællesudbud vedrørende levering af stomiprodukter mv.
France – Medical equipments, pharmaceuticals and personal care products – FOURNITURE, INSTALLATION, MISE EN SERVICE ET EVOLUTIVITED’UN SPECTROMETRE DE TYPE LC/MS TRIPLE QUADRUPOLE EQUIPE D’UNE UHPLC,FOURNITURE D’ACCESSOIRES, DE PIECES DETACHEESET DE MAINTENANCE ASSOCIES
Norway – Medical equipments, pharmaceuticals and personal care products – Drainage set for pleura and peritoneal drainage for the health authorities in The South-East Health Authority.
Norway – Medical gases – Medical oxygen framework agreement
Norway – Medical equipments, pharmaceuticals and personal care products – X-ray laboratory
Ocena szansy
Skąd ta ocena?
Szansa
45 / 100
Złożoność
40 / 100
Czynniki ryzyka
The absence of estimated contract value prevents bidders from assessing potential revenue and deciding whether to bid.
Award criteria are not specified, making it impossible to know how tenders will be evaluated.
Submission deadline in 3 days
Głęboka analiza portfolio
Wykorzystuje:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications